D-381-2014 Class I Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-381-2014 was initiated by Hospira Inc. on Jul 12, 2013 and is designated Class I. Reason for recall: Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials. The recall status is terminated (terminated Feb 3, 2015). Affected quantity: 119,600 vials.

Recall Details

Product Type
Drugs
Report Date
Dec 25, 2013
Initiation Date
Jul 12, 2013
Termination Date
Feb 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
119,600 vials

Product Description

0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02

Reason for Recall

Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.

Distribution Pattern

Nationwide

Code Information

Lot # 23-338-DK, Exp. 11/14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-381-2014
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.